CA2000401A1 - Preparation pharmaceutique a administration percutanee - Google Patents

Preparation pharmaceutique a administration percutanee

Info

Publication number
CA2000401A1
CA2000401A1 CA2000401A CA2000401A CA2000401A1 CA 2000401 A1 CA2000401 A1 CA 2000401A1 CA 2000401 A CA2000401 A CA 2000401A CA 2000401 A CA2000401 A CA 2000401A CA 2000401 A1 CA2000401 A1 CA 2000401A1
Authority
CA
Canada
Prior art keywords
base material
active ingredient
adhesive base
pharmaceutical preparation
percutaneous pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2000401A
Other languages
English (en)
Other versions
CA2000401C (fr
Inventor
Masato Azuma
Hiroko Tsukahara
Hiroshi Kuroda
Mutsumi Fukuda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shire Holdings Ltd
Original Assignee
Sekisui Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP63256379A external-priority patent/JP2552716B2/ja
Priority claimed from JP1016622A external-priority patent/JPH02196714A/ja
Priority claimed from JP5477989A external-priority patent/JPH0780772B2/ja
Priority claimed from JP1150986A external-priority patent/JPH0317018A/ja
Priority claimed from JP1178537A external-priority patent/JPH0344326A/ja
Priority claimed from JP1178538A external-priority patent/JP2507068B2/ja
Application filed by Sekisui Chemical Co Ltd filed Critical Sekisui Chemical Co Ltd
Publication of CA2000401A1 publication Critical patent/CA2000401A1/fr
Application granted granted Critical
Publication of CA2000401C publication Critical patent/CA2000401C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CA002000401A 1988-10-11 1989-10-10 Preparation pharmaceutique a administration percutanee Expired - Lifetime CA2000401C (fr)

Applications Claiming Priority (12)

Application Number Priority Date Filing Date Title
JP63256379A JP2552716B2 (ja) 1988-10-11 1988-10-11 経皮吸収貼付剤
JP63-256379 1988-10-11
JP1016622A JPH02196714A (ja) 1989-01-26 1989-01-26 経皮吸収貼付剤
JP1-16622 1989-01-26
JP5477989A JPH0780772B2 (ja) 1989-03-07 1989-03-07 経皮吸収製剤
JP1-54779 1989-03-07
JP1-150986 1989-06-14
JP1150986A JPH0317018A (ja) 1989-06-14 1989-06-14 経皮吸収製剤
JP1178537A JPH0344326A (ja) 1989-07-10 1989-07-10 経皮吸収製剤
JP1178538A JP2507068B2 (ja) 1989-07-10 1989-07-10 経皮吸収製剤
JP1-178538 1989-07-10
JP1-178537 1989-07-10

Publications (2)

Publication Number Publication Date
CA2000401A1 true CA2000401A1 (fr) 1990-04-11
CA2000401C CA2000401C (fr) 1996-05-28

Family

ID=27548670

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002000401A Expired - Lifetime CA2000401C (fr) 1988-10-11 1989-10-10 Preparation pharmaceutique a administration percutanee

Country Status (5)

Country Link
US (1) US5200190A (fr)
EP (1) EP0364211B1 (fr)
KR (1) KR970007900B1 (fr)
CA (1) CA2000401C (fr)
DE (1) DE68920109T2 (fr)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5232703A (en) * 1989-07-21 1993-08-03 Izhak Blank Estradiol compositions and methods for topical application
DE69007886T2 (de) * 1989-07-21 1994-11-17 Izhak Blank Östradiol enthaltende Mittel und Verfahren zur topischen Anwendung.
JP3273430B2 (ja) * 1989-12-28 2002-04-08 日東電工株式会社 エストロゲン含有ゲル製剤
JP2820306B2 (ja) * 1990-02-27 1998-11-05 積水化学工業株式会社 経皮吸収製剤
US5762952A (en) * 1993-04-27 1998-06-09 Hercon Laboratories Corporation Transdermal delivery of active drugs
AU692504B2 (en) * 1993-12-27 1998-06-11 Akzo Nobel N.V. Percutaneously absorbable preparation
DE4400770C1 (de) * 1994-01-13 1995-02-02 Lohmann Therapie Syst Lts Wirkstoffhaltiges Pflaster zur Abgabe von Estradiol mit mindestens einem Penetrationsverstärker, Verfahren zu seiner Herstellung und seine Verwendung
ATE194281T1 (de) * 1994-09-14 2000-07-15 Minnesota Mining & Mfg Matrix für transdermale wirkstofffreisetzung
US5573778A (en) * 1995-03-17 1996-11-12 Adhesives Research, Inc. Drug flux enhancer-tolerant pressure sensitive adhesive composition
DE19629468A1 (de) * 1996-07-11 1998-01-15 Schering Ag Transdermale therapeutische Systeme
US5783208A (en) * 1996-07-19 1998-07-21 Theratech, Inc. Transdermal drug delivery matrix for coadministering estradiol and another steroid
GB9826656D0 (en) 1998-12-03 1999-01-27 Novartis Ag Organic compounds
US6495229B1 (en) * 1999-09-17 2002-12-17 Avery Dennison Corporation Pattern coated adhesive article
AU1262501A (en) * 1999-11-12 2001-05-30 Pharmaderm Laboratories, Ltd. Compositions for transdermal and transmucosal administration of therapeutic agents
USRE44145E1 (en) 2000-07-07 2013-04-09 A.V. Topchiev Institute Of Petrochemical Synthesis Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
US20040002482A1 (en) * 2000-08-30 2004-01-01 Dudley Robert E. Androgen pharmaceutical composition and method for treating depression
EP1366762B1 (fr) * 2001-03-07 2015-12-30 Hisamitsu Pharmaceutical Co., Inc. Timbre adhesif
US8840918B2 (en) 2001-05-01 2014-09-23 A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences Hydrogel compositions for tooth whitening
EP1390084B1 (fr) * 2001-05-01 2011-03-23 A.V. Topchiev Institute of Petrochemical Synthesis Composition bioadhesive biphase absorbant l'eau
US20050215727A1 (en) 2001-05-01 2005-09-29 Corium Water-absorbent adhesive compositions and associated methods of manufacture and use
CA2445086C (fr) * 2001-05-01 2008-04-08 A.V. Topchiev Institute Of Petrochemical Synthesis Compositions d'hydrogel
US20050113510A1 (en) 2001-05-01 2005-05-26 Feldstein Mikhail M. Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components
US8541021B2 (en) * 2001-05-01 2013-09-24 A.V. Topchiev Institute Of Petrochemical Synthesis Hydrogel compositions demonstrating phase separation on contact with aqueous media
US8206738B2 (en) 2001-05-01 2012-06-26 Corium International, Inc. Hydrogel compositions with an erodible backing member
US20040241240A1 (en) * 2001-08-10 2004-12-02 Takaaki Terahara Percutaneous absorption preparations
JP3884433B2 (ja) * 2001-11-10 2007-02-21 キム、デシック 表面プラスモン光学装置及びフォトリソグラフィー用光放出表面プラスモンソース
WO2004054544A1 (fr) * 2002-12-10 2004-07-01 Besins International Belgique Composition pharmaceutique pour administration transdermique ou transmuqueuse comprenant un progestatif et un oestrogene, son procede de preparation et ses utilisations
FR2848112B1 (fr) * 2002-12-10 2007-02-16 Besins Int Belgique Composition pharmaceutique pour administration transdermique ou transmuqueuse comprenant au moins un progestatif et/ou au moins un oestrogene, son procede de preparation et ses utilisations
FR2851470B1 (fr) 2003-02-20 2007-11-16 Besins Int Belgique Composition pharmaceutique pour administration transdermique ou transmuqueuse
JP4422430B2 (ja) * 2003-05-14 2010-02-24 帝國製薬株式会社 エストロゲン及び／又はプロゲストゲン含有外用貼付剤
KR20070007299A (ko) 2004-01-30 2007-01-15 코리움 인터네셔널, 인크. 활성제의 전달을 위한 급속 용해 필름
KR100791574B1 (ko) * 2004-05-10 2008-01-03 막스-보른 인스티튜트 푸트 니히트리네아데 옵틱 운트 쿠르짜이트쉬펙트로시코피 표면 플라즈몬 광학장치 및 포토리소그라피용 빛방출표면플라즈몬 소스
AU2005271259B2 (en) 2004-08-05 2012-01-19 A.V. Topchiev Institute Of Petrochemical Synthesis Adhesive composition
US20060121102A1 (en) * 2004-09-27 2006-06-08 Chia-Ming Chiang Transdermal systems for the delivery of estrogens and progestins
DK2450041T3 (en) 2005-10-12 2018-11-19 Unimed Pharmaceuticals Llc Enhanced testosterone gel for use in the treatment of hypogonadism
CA2751884C (fr) 2009-01-14 2018-09-25 Corium International, Inc. Administration transdermique de tamsulosine
US10080760B2 (en) 2009-10-27 2018-09-25 Besins Healthcare Luxembourg Sarl Transdermal pharmaceutical compositions comprising active agents
KR102208466B1 (ko) 2019-06-18 2021-01-26 김종만 다양한 성형이 가능한 자동 벽돌 제조 장치

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4379454A (en) * 1981-02-17 1983-04-12 Alza Corporation Dosage for coadministering drug and percutaneous absorption enhancer
ATE42901T1 (de) * 1984-03-05 1989-05-15 Nitto Denko Corp Haftendes arzneimittelpraeparat fuer perkutane absorption.
AU563054B2 (en) * 1984-10-24 1987-06-25 Sekisui Kagaku Kogyo Kabushiki Kaisha Percutaneous tape of isdn
DE3587616D1 (de) * 1984-12-22 1993-11-11 Sanol Arznei Schwarz Gmbh Wirkstoffpflaster.
US4818540A (en) * 1985-02-25 1989-04-04 Rutgers, The State University Of New Jersey Transdermal fertility control system and process
US4751087A (en) * 1985-04-19 1988-06-14 Riker Laboratories, Inc. Transdermal nitroglycerin delivery system
JP2931002B2 (ja) * 1988-02-26 1999-08-09 ライカー ラボラトリース インコーポレーテッド 皮膚透過エストラジオールデリバリーシステム

Also Published As

Publication number Publication date
EP0364211B1 (fr) 1994-12-21
KR970007900B1 (ko) 1997-05-17
US5200190A (en) 1993-04-06
KR900005968A (ko) 1990-05-07
AU4268089A (en) 1990-04-26
EP0364211A1 (fr) 1990-04-18
DE68920109D1 (de) 1995-02-02
AU628866B2 (en) 1992-09-24
CA2000401C (fr) 1996-05-28
DE68920109T2 (de) 1995-05-11

Similar Documents

Publication Publication Date Title
CA2000401A1 (fr) Preparation pharmaceutique a administration percutanee
CA2153572A1 (fr) Systeme therapeutique pour administration transdermique, avec la galanthamine comme principe actif
CA2179040A1 (fr) Timbre pour administration percutanee d'un medicament
EP0701816B1 (fr) Préparation pour absorption percutanée contenant du dinitrate d'isosorbitol
US4420470A (en) Percutaneous absorption type pharmaceutical preparation of isosorbide dinitrate or pentaerythritol tetranitrate in pressure-sensitive laminate
CA2045290A1 (fr) Plate ayant une haute teneur en ingredients emollients
KR100569051B1 (ko) 항산화제를 함유하는 티티에스
AU613814B2 (en) Transdermal therapeutical system comprising physostigmine as active component and process for the production thereof
DE68912443D1 (de) Unterbrochene Haftklebeoberfläche.
CA2056653A1 (fr) Preparation pour administration de medicament par voie transdermique
CA2016039A1 (fr) Formules pharmaceutiques a delitement progressif
AU632182B2 (en) Transdermal therapeutic system comprising as active component buprenorphine
MY109939A (en) Patches for percutaneous administration of skin- whitening materials
EP0138551A3 (fr) Système pour l'administration transdermique de nitroglicérine
CA2006511A1 (fr) Preparation percutanee de tulobuterol
CA2146723A1 (fr) Preparation pour absorption percutanee
CA2140468A1 (fr) Preparation sur ruban pour administration percutanee
US6165498A (en) Transdermal preparation containing a loratidine metabolite with antihistaminic activity
JPS6442432A (en) Transdermal delivery system
EP0337358A3 (en) Percutaneous absorption type preparation and process for preparing the same
JPS6468316A (en) External plaster containing salbutamol
CA2300339A1 (fr) Systeme therapeutique transdermique contenant le principe actif scopolamine base
CA2002761A1 (fr) Preparation de clonidine sur bande adhesive
CA2089371A1 (fr) Composes pharmaceutiques a revetement sur le bord lateral et a liberation lente
GB1510569A (en) Dosage form for the administration of a medicament to a moist body surface

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry